Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice

Biochemical and Biophysical Research Communications

Volumn 340, Issue 4, 2006, Pages 1125-1133

  Tsukamoto, Osamu ^a   Minamino, Tetsuo ^a   Okada, Ken Ichiro ^a   Shintani, Yasunori ^a   Takashima, Seiji ^a   Kato, Hisakazu ^a   Liao, Yulin ^a   Okazaki, Hidetoshi ^b   Asai, Mitsutoshi ^a   Hirata, Akio ^a   Fujita, Masashi ^a   Asano, Yoshihiro ^a   Yamazaki, Satoru ^b   Asanuma, Hiroshi ^b   Hori, Masatsugu ^a   Kitakaze, Masafumi ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Apoptosis; Heart failure; Protein degradation; Ubiquitin proteasome

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; MESSENGER RNA; PROTEASOME; PROTEIN BAX; PROTEIN P53; SMALL INTERFERING RNA; UBIQUITIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CASE REPORT; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME INACTIVATION; GENE SILENCING; HEART DISEASE; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE OVERLOAD; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINASE INHIBITION; RAT; RNA INTERFERENCE;

ADULT; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MYOCARDIUM; MYOCYTES, CARDIAC; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, INBRED WKY; UBIQUITIN;

ANIMALIA;

EID: 30544446127     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.12.120     Document Type: Article

References (45)

1. M. Hochstrasser Ubiquitin, proteasomes, and the regulation of intracellular protein degradation Curr. Opin. Cell Biol. 7 1995 215 223
2. S. Jentsch, and S. Schlenker Selective protein degradation: a journey's end within the proteasome Cell 82 1995 881 884
3. A. Hershko, and A. Ciechanover The ubiquitin system Annu. Rev. Biochem. 67 1998 425 479
4. M.H. Glickman, and A. Ciechanover The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction Physiol. Rev. 82 2002 373 428
5. A. Ciechanover The ubiquitin-proteasome pathway: on protein death and cell life EMBO J. 17 1998 7151 7160
6. C.G. Maki, J.M. Huibregtse, and P.M. Howley In vivo ubiquitination and proteasome-mediated degradation of p53(1) Cancer Res. 56 1996 2649 2654
7. S.E. Salghetti, S.Y. Kim, and W.P. Tansey Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc EMBO J. 18 1999 717 726
8. S. Dimmeler, K. Breitschopf, J. Haendeler, and A.M. Zeiher Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway J. Exp. Med. 189 1999 1815 1822
9. Y. Yang, S. Fang, J.P. Jensen, A.M. Weissman, and J.D. Ashwell Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli Science 288 2000 874 877
10. C. Naujokat, and S. Hoffmann Role and function of the 26S proteasome in proliferation and apoptosis Lab. Invest. 82 2002 965 980
11. H.C. Drexler Activation of the cell death program by inhibition of proteasome function Proc. Natl. Acad. Sci. USA 94 1997 855 860
12. J.H. Qiu, A. Asai, S. Chi, N. Saito, H. Hamada, and T. Kirino Proteasome inhibitors induce cytochrome c -caspase-3-like protease-mediated apoptosis in cultured cortical neurons J. Neurosci. 20 2000 259 265
13. H.C. Drexler, W. Risau, and M.A. Konerding Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells FASEB J. 14 2000 65 77
14. J. Adams, V.J. Palombella, E.A. Sausville, J. Johnson, A. Destree, D.D. Lazarus, J. Maas, C.S. Pien, S. Prakash, and P.J. Elliott Proteasome inhibitors: a novel class of potent and effective antitumor agents Cancer Res. 59 1999 2615 2622
15. M. Jessup, and S. Brozena Heart failure N. Engl. J. Med. 348 2003 2007 2018
16. W. Grossman, D. Jones, and L.P. McLaurin Wall stress and patterns of hypertrophy in the human left ventricle J. Clin. Invest. 56 1975 56 64
17. D. Huber, J. Grimm, R. Koch, and H.P. Krayenbuehl Determinants of ejection performance in aortic stenosis Circulation 64 1981 126 134
18. M.T. Crow, K. Mani, Y.J. Nam, and R.N. Kitsis The mitochondrial death pathway and cardiac myocyte apoptosis Circ. Res. 95 2004 957 970
19. K. Okada, T. Minamino, Y. Tsukamoto, Y. Liao, O. Tsukamoto, S. Takashima, A. Hirata, M. Fujita, Y. Nagamachi, T. Nakatani, C. Yutani, K. Ozawa, S. Ogawa, H. Tomoike, M. Hori, and M. Kitakaze Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis Circulation 110 2004 705 712
20. T. Minamino, V. Gaussin, F.J. DeMayo, and M.D. Schneider Inducible gene targeting in postnatal myocardium by cardiac-specific expression of a hormone-activated Cre fusion protein Circ. Res. 88 2001 587 592
21. K. Nakamura, K. Kusano, Y. Nakamura, M. Kakishita, K. Ohta, S. Nagase, M. Yamamoto, K. Miyaji, H. Saito, H. Morita, T. Emori, H. Matsubara, S. Toyokuni, and T. Ohe Carvedilol decreases elevated oxidative stress in human failing myocardium Circulation 105 2002 2867 2871
22. Y. Liao, F. Ishikura, S. Beppu, M. Asakura, S. Takashima, H. Asanuma, S. Sanada, J. Kim, H. Ogita, T. Kuzuya, K. Node, M. Kitakaze, and M. Hori Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation Am. J. Physiol. Heart Circ. Physiol. 282 2002 H1703 H1708
23. K. Okada, C. Wangpoengtrakul, T. Osawa, S. Toyokuni, K. Tanaka, and K. Uchida 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules J. Biol. Chem. 274 1999 23787 23793
24. A.L. Bulteau, K.C. Lundberg, K.M. Humphries, H.A. Sadek, P.A. Szweda, B. Friguet, and L.I. Szweda Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion J. Biol. Chem. 276 2001 30057 30063
25. A.R. Kumarapeli, K.M. Horak, J.W. Glasford, J. Li, Q. Chen, J. Liu, H. Zheng, and X. Wang A novel transgenic mouse model reveals deregulation of the ubiquitin-proteasome system in the heart by doxorubicin FASEB J. 2005
26. Q. Chen, J.B. Liu, K.M. Horak, H. Zheng, A.R. Kumarapeli, J. Li, F. Li, A.M. Gerdes, E.F. Wawrousek, and X. Wang Intrasarcoplasmic amyloidosis impairs proteolytic function of proteasomes in cardiomyocytes by compromising substrate uptake Circ. Res. 97 2005 1018 1026
27. D.J. Lips, L.J. deWindt, D.J. van Kraaij, and P.A. Doevendans Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy Eur. Heart J. 24 2003 883 896
28. S. Hein, E. Arnon, S. Kostin, M. Schonburg, A. Elsasser, V. Polyakova, E.P. Bauer, W.P. Klovekorn, and J. Schaper Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms Circulation 107 2003 984 991
29. N. Chondrogianni, and E.S. Gonos Proteasome dysfunction in mammalian aging: steps and factors involved Exp. Gerontol. 2005
30. B. Li, and Q.P. Dou Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression Proc. Natl. Acad. Sci. USA 97 2000 3850 3855
31. Y. Yang, and X. Yu Regulation of apoptosis: the ubiquitous way FASEB J. 17 2003 790 799
32. B. Vogelstein, D. Lane, and A.J. Levine Surfing the p53 network Nature 408 2000 307 310
33. V. Jesenberger, and S. Jentsch Deadly encounter: ubiquitin meets apoptosis Nat. Rev. Mol. Cell Biol. 3 2002 112 121
34. M. MacFarlane, W. Merrison, S.B. Bratton, and G.M. Cohen Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro J. Biol. Chem. 277 2002 36611 36616
35. M.M. Mortenson, M.G. Schlieman, S. Virudachalam, P.N. Lara, D.G. Gandara, A.M. Davies, and R.J. Bold Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer Lung Cancer 49 2005 163 170
36. D. Yin, H. Zhou, T. Kumagai, G. Liu, J.M. Ong, K.L. Black, and H.P. Koeffler Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM) Oncogene 24 2005 344 354
37. P.G. Sullivan, N.B. Dragicevic, J.H. Deng, Y. Bai, E. Dimayuga, Q. Ding, Q. Chen, A.J. Bruce-Keller, and J.N. Keller Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover J. Biol. Chem. 279 2004 20699 20707
38. V. Marshansky, X. Wang, R. Bertrand, H. Luo, W. Duguid, G. Chinnadurai, N. Kanaan, M.D. Vu, and J. Wu Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells J. Immunol. 166 2001 3130 3142
39. Y.H. Ling, L. Liebes, Y. Zou, and R. Perez-Soler Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells J. Biol. Chem. 278 2003 33714 33723
40. N. Chondrogianni, C. Tzavelas, A.J. Pemberton, I.P. Nezis, A.J. Rivett, and E.S. Gonos Overexpression of proteasome beta5 assembled subunit increases the amount of proteasome and confers ameliorated response to oxidative stress and higher survival rates J. Biol. Chem. 280 2005 11840 11850
41. T. Grune, T. Reinheckel, and K.J. Davies Degradation of oxidized proteins in mammalian cells FASEB J. 11 1997 526 534
42. M.W. Knaapen, M.J. Davies, M. De Bie, A.J. Haven, W. Martinet, and M.M. Kockx Apoptotic versus autophagic cell death in heart failure Cardiovasc. Res. 51 2001 304 312
43. S. Kostin, L. Pool, A. Elsasser, S. Hein, H.C. Drexler, E. Arnon, Y. Hayakawa, R. Zimmermann, E. Bauer, W.P. Klovekorn, and J. Schaper Myocytes die by multiple mechanisms in failing human hearts Circ. Res. 92 2003 715 724
44. J. Yuan, M. Lipinski, and A. Degterev Diversity in the mechanisms of neuronal cell death Neuron 40 2003 401 413
45. T. Shintani, and D.J. Klionsky Autophagy in health and disease: a double-edged sword Science 306 2004 990 995